2020 annual financial data
Dogwood Therapeutics 2020 Revenue growth
Direct answer
Revenue growth was Not calculable.
Operating income was -10,005,394 USD and net income was -10,346,395 USD.
Operating cash flow was -3,895,195 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,005,394 USD
- Net income
- -10,346,395 USD
- Operating cash flow
- -3,895,195 USD